Back to Search Start Over

GOSAFE - Geriatric Oncology Surgical Assessment and Functional rEcovery after Surgery: early analysis on 977 patients

Authors :
Barbara Frezza
Giampaolo Castagnoli
Genoveffa Balducci
Valentina Riggio
G. Ugolini
Antonio Arroyo
Gianluca Garulli
Caterina Foppa
Kristin Cardin
Matthijs Plas
Gaetano Gallo
Francesca De Lucia
Francisco López-Rodríguez
Sandra Lario
Franco De Cian
Flavia Foca
Alberto Realis Luc
Paola Tramelli
Roberta Pellegrino
Giacomo Sermonesi
Stefano Sfondrini
Federico Ghignone
Orestis Ioannidis
Nicole M. Saur
Michael David Fejka
Basilio Pirrera
Bruno Alampi
Siri Rostoft
Sam Fox
Chiara Zingaretti
Ingeborg Flåten Backe
Alessandro Spaziani
Barbara Perenze
Minas Baltatzis
Riccardo A. Audisio
Claudia Santos
Luigi Marano
Mariann Lønn
Stefano Scabini
Andrea Massobrio
Patrizio Capelli
Isacco Montroni
Luis E. De León
Cristina Lillo
Alessio Lucarini
Valerio Belgrano
Antonino Spinelli
Daniela Di Pietrantonio
Nicola de Liguori Carino
Davide Pertile
Luigi Conti
Andrea Romboli
Giuseppe Sammarco
Hanoch Kashtan
Baha Siam
Michael T. Jaklitsch
Arild Nesbakken
Michele De Simone
Oriana Nanni
Filippo Banchini
Ajith K. Siriwardena
Giorgio Ercolani
Pietro Achilli
Davide Zattoni
Bernadette Vertogen
Steven D. Wexner
Laura Frain
Konstantinos Galanos-Demiris
Dario Maggioni
Baruch Brenner
Gerardo Palmieri
Giovanni Taffurelli
Barbara L. van Leeuwen
Manuela Albertelli
Gianluca Pellino
Anthony Chan
Alberto Bartoli
Emanuela Stratta
Mario Trompetto
Anna Garutti
Francesca Tauceri
Michele Mazzola
Beatrice Palermo
G. Clerico
Jakub Kenig
Yochai Levy
Graziana Barile
Vincenzo Alagna
Giulio Mari
Roberto Eggenhöffner
Joshua I. S. Bleier
Giovanni Ferrari
Andrea Costanzi
Michele Carvello
Francesca Di Candido
Francesco Monari
Ponnandai Somasundar
Kinga Szabat
Matteo Sacchi
Luis Sánchez-Guillén
Lydia Loutzidou
Lisa Cooper
Hanneke van der Wal-Huisman
Mariateresa Mirarchi
Domenico Soriero
Raffaele De Luca
Andrea Lucchi
Damage and Repair in Cancer Development and Cancer Treatment (DARE)
Guided Treatment in Optimal Selected Cancer Patients (GUTS)
Clinical Cognitive Neuropsychiatry Research Program (CCNP)
Montroni I.
Rostoft S.
Spinelli A.
Van Leeuwen B.L.
Ercolani G.
Saur N.M.
Jacklitsh M.T.
Somasundar P.S.
de Liguori Carino N.
Ghignone F.
Foca F.
Zingaretti C.
Audisio R.A.
Ugolini G.
Garutti A.
Taffurelli G.
Zattoni D.
Tramelli P.
Sermonesi G.
Di Candido F.
Carvello M.
Sacchi M.
De Lucia F.
Foppa C.
Plas M.
Van der Wal-Huisman H.
Tauceri F.
Perenze B.
Di Pietrantonio D.
Mirarchi M.
Fejka M.
Bleier J.I.S.
Frain L.
Fox S.W.
Cardin K.
De Leon L.E.
Baltatzis M.
Chan A.K.C.
Siriwardena A.K.
Vertogen B.
Nanni O.
Garulli G.
Alagna V.
Pirrera B.
Lucchi A.
Monari F.
Conti L.
Capelli P.
Romboli A.
Palmieri G.
Banchini F.
Marano L.
Spaziani A.
Castagnoli G.
Bartoli A.
Trompetto M.
Gallo G.
Luc A.R.
Clerico G.
Sammarco G.
De Luca R.
Barile G.
Simone M.
Costanzi A.
Mari G.
Maggioni M.
Pellegrino R.
Riggio V.
Kenig J.
Szabat K.
Scabini S.
Pertile D.
Stratta E.
Massobrio A.
Soriero D.
Nesbakken A.
Lonn M.
Backe I.F.
Ferrari G.
Mazzola M.
Alampi B.D.A.
Achilli P.
Sfondrini S.
Ioannidis O.
Loutzidou L.
Galanos-Demiris K.
Pellino G.
Balducci G.
Frezza B.
Lucarini A.
Santos C.
Cooper L.
Siam B.
Levy Y.
Brenner B.
Kashtan H.
Belgrano V.
De Cian F.
Palermo B.
Eggenhoffner R.
Albertelli M.
Sanchez-Guillen L.
Arroyo A.
Lopez-Rodriguez F.
Lario S.
Lillo C.
Wexner S.D.
Montroni, I.
Rostoft, S.
Spinelli, A.
Van Leeuwen, B. L.
Ercolani, G.
Saur, N. M.
Jacklitsh, M. T.
Somasundar, P. S.
de Liguori Carino, N.
Ghignone, F.
Foca, F.
Zingaretti, C.
Audisio, R. A.
Ugolini, G.
Garutti, A.
Taffurelli, G.
Zattoni, D.
Tramelli, P.
Sermonesi, G.
Di Candido, F.
Carvello, M.
Sacchi, M.
De Lucia, F.
Foppa, C.
Plas, M.
Van der Wal-Huisman, H.
Tauceri, F.
Perenze, B.
Di Pietrantonio, D.
Mirarchi, M.
Fejka, M.
Bleier, J. I. S.
Frain, L.
Fox, S. W.
Cardin, K.
De Leon, L. E.
Baltatzis, M.
Chan, A. K. C.
Siriwardena, A. K.
Vertogen, B.
Nanni, O.
Garulli, G.
Alagna, V.
Pirrera, B.
Lucchi, A.
Monari, F.
Conti, L.
Capelli, P.
Romboli, A.
Palmieri, G.
Banchini, F.
Marano, L.
Spaziani, A.
Castagnoli, G.
Bartoli, A.
Trompetto, M.
Gallo, G.
Luc, A. R.
Clerico, G.
Sammarco, G.
De Luca, R.
Barile, G.
Simone, M.
Costanzi, A.
Mari, G.
Maggioni, M.
Pellegrino, R.
Riggio, V.
Kenig, J.
Szabat, K.
Scabini, S.
Pertile, D.
Stratta, E.
Massobrio, A.
Soriero, D.
Nesbakken, A.
Lonn, M.
Backe, I. F.
Ferrari, G.
Mazzola, M.
Alampi, B. D. A.
Achilli, P.
Sfondrini, S.
Ioannidis, O.
Loutzidou, L.
Galanos-Demiris, K.
Pellino, G.
Balducci, G.
Frezza, B.
Lucarini, A.
Santos, C.
Cooper, L.
Siam, B.
Levy, Y.
Brenner, B.
Kashtan, H.
Belgrano, V.
De Cian, F.
Palermo, B.
Eggenhoffner, R.
Albertelli, M.
Sanchez-Guillen, L.
Arroyo, A.
Lopez-Rodriguez, F.
Lario, S.
Lillo, C.
Wexner, S. D.
Source :
Journal of Geriatric Oncology, 11(2), 244-255. ELSEVIER SCIENCE BV
Publication Year :
2019

Abstract

Objective: Older patients with cancer value functional outcomes as much as survival, but surgical studies lack functional recovery (FR) data. The value of a standardized frailty assessment has been confirmed, yet it's infrequently utilized due to time restrictions into everyday practice. The multicenter GOSAFE study was designed to (1) evaluate the trajectory of patients' quality of life (QoL) after cancer surgery (2) assess baseline frailty indicators in unselected patients (3) clarify the most relevant tools in predicting FR and clinical outcomes. This is a report of the study design and baseline patient evaluations. Materials & Methods: GOSAFE prospectively collected a baseline multidimensional evaluation before major elective surgery in patients (≥70 years) from 26 international units. Short−/mid−/long-term surgical outcomes were recorded with QoL and FR data. Results: 1003 patients were enrolled in a 26-month span. Complete baseline data were available for 977(97.4%). Median age was 78 years (range 70–94); 52.8% males. 968(99%) lived at home, 51.6% without caregiver. 54.4% had ≥ 3 medications, 5.9% none. Patients were dependent (ADL < 5) in 7.9% of the cases. Frailty was either detected by G8 ≤ 14(68.4%), fTRST ≥ 2(37.4%), TUG > 20 s (5.2%) or ASAIII-IV (48.8%). Major comorbidities (CACI > 6) were detected in 36%; 20.9% of patients had cognitive impairment according to Mini-Cog. Conclusion: The GOSAFE showed that frailty is frequent in older patients undergoing cancer surgery. QoL and FR, for the first time, are going to be primary outcomes of a real-life observational study. The crucial role of frailty assessment is going to be addressed in the ability to predict postoperative outcomes and to correlate with QoL and FR.

Details

ISSN :
18794076 and 18794068
Volume :
11
Issue :
2
Database :
OpenAIRE
Journal :
Journal of geriatric oncology
Accession number :
edsair.doi.dedup.....88f6fc3ff78289649ad950b57344ad37